Taiwan FDA registration 2ad13352889473ebe18c0fdac284c314
Mumps virus (IgM) serum reagent
TW: 常盈腮腺炎病毒(IgM)血清試劑
Taiwan·Risk Class 2·IBL INTERNATIONAL GMBH·Registered Jan 26, 2006 – Jan 26, 2016CancelledRegistration details
- Analysis ID
- 2ad13352889473ebe18c0fdac284c314
- Customs Code
- DHA00601595207
Company information
- Manufacturer
- IBL INTERNATIONAL GMBH
- Manufacturer Country
- Germany
- Authorized Representative
- WOLCH ENTERPRISES INC.
Product details
- Intended Use
- Enzyme immunoquantification was used to detect Mumps IgM in serum and blood cells.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.3380 腮腺炎病毒血清試劑
- Import Information
- import
Dates and status
- Registration Date
- Jan 26, 2006
- Expiry Date
- Jan 26, 2016
- Cancellation Date
- Apr 25, 2018
Cancellation information
- Status
- Logged out
- Reason
- 自行鍵入
About this record
Access comprehensive regulatory information for Mumps virus (IgM) serum reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 2ad13352889473ebe18c0fdac284c314 and manufactured by IBL INTERNATIONAL GMBH. The authorized representative in Taiwan is WOLCH ENTERPRISES INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices